Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten O Nielsen

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Molecular Diagnostics : JMD|December 21, 2020
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated LiposarcomasXiu Q Wang, Xue Q Wang, Anika T Y W Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical TrialsKarama Asleh, Dongsheng Tu, Dongxia Gao, et al.
Cancer|March 17, 2005
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survivalSam M Wiseman, Nikita Makretsov, Torsten O Nielsen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 6, 2018
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator studyBalazs Acs, Vasiliki Pelekanou, Yalai Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.
Acta Oncologica (Stockholm, Sweden)|December 24, 2013
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patientsCharlotte L T Jørgensen, Torsten O Nielsen, Karsten D Bjerre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical TrialKarama Asleh, Heather Ann Brauer, Amy Sullivan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 3, 2019
Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomasAmanda R Dancsok, Nokitaka Setsu, Dongxia Gao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2002
Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistryForrest D Hsu, Torsten O Nielsen, Abdulmohsen Alkushi, et al.
Breast Cancer Research : BCR|February 19, 2008
Are triple-negative tumours and basal-like breast cancer synonymous?Emad A Rakha, David S P Tan, William D Foulkes, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Molecular Diagnostics : JMD|December 21, 2020
A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated LiposarcomasXiu Q Wang, Xue Q Wang, Anika T Y W Hsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical TrialsKarama Asleh, Dongsheng Tu, Dongxia Gao, et al.
Cancer|March 17, 2005
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survivalSam M Wiseman, Nikita Makretsov, Torsten O Nielsen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 6, 2018
Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator studyBalazs Acs, Vasiliki Pelekanou, Yalai Bai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeMaggie C U Cheang, David Voduc, Chris Bajdik, et al.
Acta Oncologica (Stockholm, Sweden)|December 24, 2013
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patientsCharlotte L T Jørgensen, Torsten O Nielsen, Karsten D Bjerre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical TrialKarama Asleh, Heather Ann Brauer, Amy Sullivan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 3, 2019
Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomasAmanda R Dancsok, Nokitaka Setsu, Dongxia Gao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 14, 2002
Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistryForrest D Hsu, Torsten O Nielsen, Abdulmohsen Alkushi, et al.
Breast Cancer Research : BCR|February 19, 2008
Are triple-negative tumours and basal-like breast cancer synonymous?Emad A Rakha, David S P Tan, William D Foulkes, et al.
Pageof 22